0001706603-17-000002.txt : 20170605 0001706603-17-000002.hdr.sgml : 20170605 20170605122843 ACCESSION NUMBER: 0001706603-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170605 DATE AS OF CHANGE: 20170605 EFFECTIVENESS DATE: 20170605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Third Coast Therapeutics, Inc. CENTRAL INDEX KEY: 0001706603 IRS NUMBER: 463055758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-288032 FILM NUMBER: 17890394 BUSINESS ADDRESS: STREET 1: 600 DAVIS STREET CITY: EVANSTON STATE: IL ZIP: 60201-4488 BUSINESS PHONE: 6087725878 MAIL ADDRESS: STREET 1: 600 DAVIS STREET CITY: EVANSTON STATE: IL ZIP: 60201-4488 D 1 primary_doc.xml X0707 D LIVE 0001706603 Third Coast Therapeutics, Inc. 600 DAVIS STREET EVANSTON IL ILLINOIS 60201-4488 6087725878 DELAWARE None None Corporation true 2013 Joseph Luminiello 27074 Fenview Drive Tower Lakes IL ILLINOIS 60010 Executive Officer Director Raymond Bergan 1033 SW Gibbs St. #302 Portland OR OREGON 97239 Director Karl Scheidt 1513 Asbury Drive Evanston IL ILLINOIS 60201 Director Pharmaceuticals No Revenues 06b false 2017-02-23 false true false 5000 1200000 50000 1150000 The total amount sold represents sales to founders and directors. No sales to outside investors has yet taken place. false 3 0 0 120000 true false Third Coast Therapeutics, Inc. Joseph Luminiello Joseph Luminiello CEO, Director 2017-06-02